Stockscreener 앱 받기
105.27
2.57%
2.64
시장 영업 전:
102.60
-2.67
-2.54%
전일 마감가:
$102.63
열려 있는:
$103.43
하루 거래량:
7.50M
Relative Volume:
1.68
시가총액:
$465.74B
수익:
$39.36B
순이익/손실:
$13.79B
주가수익비율:
43.72
EPS:
2.4077
순현금흐름:
$9.83B
1주 성능:
-1.53%
1개월 성능:
-10.86%
6개월 성능:
-20.80%
1년 성능:
+1.62%
1일 변동 폭
$103.00
$105.74
1주일 범위
$99.42
$107.00
52주 변동 폭
$94.73
$148.15
노보 노디스크 Stock (NVO) Company Profile
NVO을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
| NVO | 105.27 | 465.74B | 39.36B | 13.79B | 9.83B | 2.4077 |
| LLY | 753.41 | 693.54B | 40.86B | 8.37B | -2.28B | 5.4193 |
| JNJ | 153.11 | 353.35B | 87.70B | 14.68B | 19.03B | 13.47 |
| ABBV | 167.76 | 294.70B | 55.53B | 5.12B | 15.62B | 3.65 |
| MRK | 97.44 | 248.54B | 63.17B | 12.15B | 14.84B | 1.80 |
노보 노디스크 Stock (NVO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-05-30 | 개시 | Goldman | Buy |
| 2024-04-12 | 개시 | BMO Capital Markets | Outperform |
| 2024-01-23 | 개시 | Morgan Stanley | Overweight |
| 2024-01-16 | 재개 | UBS | Neutral |
| 2023-12-01 | 개시 | Cantor Fitzgerald | Overweight |
| 2023-10-02 | 개시 | Argus | Buy |
| 2023-07-14 | 개시 | HSBC Securities | Buy |
| 2022-07-15 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2022-06-28 | 다운그레이드 | UBS | Neutral → Sell |
| 2022-06-27 | 업그레이드 | Exane BNP Paribas | Underperform → Neutral |
| 2022-06-07 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2022-05-31 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2022-04-25 | 업그레이드 | Cowen | Market Perform → Outperform |
| 2022-04-12 | 업그레이드 | Morgan Stanley | Underweight → Equal-Weight |
| 2022-03-16 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2022-01-25 | 다운그레이드 | Liberum | Hold → Sell |
| 2021-12-20 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2021-12-17 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2021-01-20 | 다운그레이드 | Credit Suisse | Outperform → Neutral |
| 2021-01-15 | 개시 | Deutsche Bank | Buy |
| 2020-09-29 | 개시 | Berenberg | Hold |
| 2020-07-06 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2020-05-11 | 다운그레이드 | UBS | Buy → Neutral |
| 2020-05-04 | 개시 | Cowen | Market Perform |
| 2020-03-16 | 업그레이드 | BofA/Merrill | Neutral → Buy |
| 2020-01-03 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2019-11-18 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2019-09-17 | 업그레이드 | Citigroup | Neutral → Buy |
| 2019-08-30 | 다운그레이드 | Jefferies | Hold → Underperform |
| 2019-06-20 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2019-06-11 | 업그레이드 | Barclays | Underweight → Equal Weight |
| 2019-04-29 | 업그레이드 | Credit Suisse | Neutral → Outperform |
| 2019-01-29 | 개시 | Exane BNP Paribas | Outperform |
| 2018-12-11 | 재개 | Jefferies | Hold |
| 2018-10-09 | 개시 | Guggenheim | Buy |
| 2017-12-29 | 업그레이드 | JP Morgan | Underweight → Neutral |
| 2017-12-06 | 업그레이드 | BofA/Merrill | Neutral → Buy |
| 2017-12-01 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2017-09-25 | 다운그레이드 | Exane BNP Paribas | Outperform → Neutral |
| 2017-09-06 | 업그레이드 | BofA/Merrill | Underperform → Neutral |
모두보기
노보 노디스크 주식(NVO)의 최신 뉴스
Novo Nordisk ADR (NYSE: NVO) Could Fell Another -55.9% - Stocks Register
Inside the Market Dominance of the Top 10 Pharma Giants - Value the Markets
Is Novo Nordisk Stock a Buy Right Now? - The Motley Fool
Biopharma Stock Election Impact: Potential Reduced IRA Headwind but Unpredictable Challenges - Morningstar
Novo Nordisk A/S (NVO) Stock Price, News, Quote & History - Yahoo Finance
NVO Misses Q3 Earnings & Revenue Estimates, Updates 2024 View - Yahoo Finance
European Equities Traded in the US as American Depositary Receipts Kick Off Week Lower in Monday Trading - MSN
Novo Nordisk ADR earnings beat by $5.24, revenue topped estimates - Investing.com Australia
European Equities Traded in the US as American Depositary Receipts Open Week Slightly Higher - MSN
India Subcutaneous Drug Delivery Devices Market Size & Outlook, 2030 - Grand View Research
Why this money manager sees FirstService, Novo Nordisk and Microsoft as good long-term holdings - The Globe and Mail
NVO: 3 European Stocks to Buy as the Region Recovers - StockNews.com
NVO’s price-to-cash ratio: How it affects the stock’s valuation. - US Post News
Market cap of Novo Nordisk ADR [NVO] reaches 391.26B – now what? - The DBT News
Analyzing Novo Nordisk ADR (NVO) After Recent Trading Activity - Knox Daily
Monitoring Melco Resorts & Entertainment Ltd ADR (MLCO) after recent insider movements - Knox Daily
Weekly Upgrades and Downgrades - InvestorPlace
Precidian to List First ADRhedged Securities in the U.S. on Cboe - Traders Magazine
Novo Nordisk Currently Down Six Consecutive Days, on Pace for Longest Losing Streak Since September 2022 — Data Talk - Morningstar
Novo Nordisk ADR (NVO) receives a Buy rating from Goldman - Knox Daily
The Attractiveness of Investing In Tenaris S.A. ADR (TS) is Growing - Knox Daily
Stock Market Recap: Novo Nordisk ADR (NVO) Concludes at 118.01, a -0.89 Surge/Decline - The Dwinnex
Banco Santander S.A. ADR [SAN] Investment Appeal on the Rise - Knox Daily
Analyzing Indonesia Energy Corp Ltd (INDO) After Recent Trading Activity - Knox Daily
노보 노디스크 (NVO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.07%
0.17%
자본화:
|
볼륨(24시간):